||Recombinant Human LY86 (Accession # O95711), fused with , was produced in Mouse myeloma cell line, NS0-derived.
|Predicted N Terminal:
||Lyophilized from a 0.2 µm filtered solution in PBS with BSA as a carrier protein.
||Measured by its ability to bind rmRP10^5/Fc Chimera in a functional ELISA.
||Recombinant Human LY86 has a calculated MW of 18.2 kDa. In SDS-PAGE migrates as 28 kDa, reducing conditions.
||>90%, by SDS-PAGE under reducing conditions and visualized by silver stain.
||Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC).